GlassScriptPhysician profile
Rodolfo Trejo
NPI 1750335584
$39,866.22
in general payments reported to CMS, 2019-2025
86 companies · $6,408 in 2025
The $6,408 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,704 · 2020: $4,515 · 2021: $6,507 · 2022: $4,407 · 2023: $5,193 · 2024: $6,132 · 2025: $6,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,733.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,712.08 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $4,087.62 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Glaxosmithkline, LLC. | $1,777.24 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $1,614.43 | 2020-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Pfizer INC. | $1,450.00 | 2019-2025 | |
| Lilly USA, LLC | $1,438.66 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Abbott Laboratories | $1,434.39 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,398.16 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Novo Nordisk INC | $1,387.85 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $1,272.52 | 2019-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $1,249.35 | 2021-2025 | |
| Esperion Therapeutics, INC. | $1,165.12 | 2020-2024 | Nexletol, Nexlizet |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $961.18 | 2022-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $948.08 | 2019-2025 | Trintellix, Eohilia |
| Astellas Pharma US INC | $877.90 | 2019-2025 | Veozah, Myrbetriq |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $847.94 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $830.56 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $770.12 | 2019-2025 | |
| Amarin Pharma, INC. | $567.03 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $557.26 | 2019-2023 | Xarelto |
| Allergan, INC. | $542.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $499.55 | 2019-2023 | Verquvo, Belsomra |
| Phathom Pharmaceuticals, INC. | $489.01 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $440.62 | 2019-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Exact Sciences Corporation | $416.37 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merz North America, INC. | $346.27 | 2020-2024 | Xeomin |
| Radius Health, INC. | $337.37 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $293.86 | 2020-2021 | |
| Aytu Biopharma, INC. | $255.55 | 2019-2020 | |
| Viiv Healthcare Company | $249.55 | 2024-2025 | Apretude |
| Lundbeck LLC | $235.01 | 2021-2025 | Rexulti |
| Eisai INC. | $220.51 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $202.03 | 2021-2025 | Zoryve |
| Sunovion Pharmaceuticals INC. | $200.76 | 2021-2022 | |
| Alkermes, INC. | $191.89 | 2022-2024 | Lybalvi, Aristada |
| Sumitomo Pharma America, INC. | $188.69 | 2023-2025 | Gemtesa, Myfembree |
| Antares Pharma, INC. | $174.69 | 2019-2022 | |
| Horizon Therapeutics Plc | $171.61 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $167.92 | 2025 | Fanapt |
| Vivus LLC | $155.53 | 2021-2023 | Qsymia |
| Biohaven Pharmaceutical Holding Company LTD. | $153.01 | 2022 | |
| Axsome Therapeutics, INC. | $149.02 | 2023-2025 | Symbravo, Auvelity, Sunosi |
| Adlon Therapeutics L.P. | $142.45 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $137.59 | 2021-2022 | |
| Verona Pharma, INC. | $135.24 | 2025 | Ohtuvayre |
| Neurocrine Biosciences, INC. | $124.99 | 2025 | |
| Incyte Corporation | $124.97 | 2025 | Opzelura |
| Boston Scientific Corporation | $120.69 | 2019 | |
| Gilead Sciences, INC. | $120.00 | 2021 | |
| Dexcom, INC. | $114.12 | 2023-2025 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $98.34 | 2023-2024 | Yupelri |
| Genentech USA, INC. | $95.21 | 2019-2022 | |
| Biogen, INC. | $93.66 | 2020-2022 | |
| Nevro Corp. | $91.96 | 2022-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $86.61 | 2021-2022 | |
| Corium, LLC | $82.94 | 2023 | Azstarys |
| Upsher-Smith Laboratories LLC | $75.87 | 2019-2020 | |
| Almatica Pharma LLC | $67.69 | 2023 | Loreev Xr, Gralise, Sertraline Hcl |
| Indivior INC. | $67.41 | 2019-2021 | |
| Medline Industries LP | $63.85 | 2019 | |
| Jazz Pharmaceuticals INC. | $60.05 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $55.76 | 2025 | Gvoke Hypopen |
| Endo Pharmaceuticals INC. | $54.92 | 2019-2020 | |
| Romark Laboratories, Lc | $51.65 | 2020 | |
| Nestle Healthcare Nutrition INC. | $38.54 | 2022 | |
| Ardelyx, INC. | $36.17 | 2025 | Ibsrela |
| Smith+Nephew, INC. | $35.87 | 2019-2023 | Collagenase Santyl |
| Impel Pharmaceuticals INC. | $34.41 | 2023 | Trudhesa |
| Aimmune Therapeutics, INC. | $31.21 | 2024 | |
| Idorsia Pharmaceuticals US INC | $29.78 | 2024-2025 | Quviviq, Quviviq |
| Alk-Abello, INC | $24.65 | 2023 | Ragwitek, Odactra, Grastek |
| Corcept Therapeutics | $20.19 | 2025 | Korlym |
| Ironwood Pharmaceuticals, INC | $20.16 | 2022 | |
| Verity Pharmaceuticals INC. | $20.14 | 2025 | Tlando |
| Redhill Biopharma INC. | $20.00 | 2020 | |
| Dermira, INC. | $18.37 | 2020 | |
| Forte Bio-Pharma LLC | $15.74 | 2024 | Prolate, Nalocet |
| Tolmar, INC. | $14.20 | 2023 | |
| Biodelivery Sciences International, INC. | $11.85 | 2020 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Airsupra $1,764Rexulti $1,395Breztri $995Qulipta $891Farxiga $852Xifaxan $794Ubrelvy $778Caplyta $751Vraylar $736Kerendia $683Linzess $657Trelegy Ellipta $575Fasenra $537Lybalvi $499Voquezna $489Nurtec Odt $440Freestyle Libre 3 $421Ozempic $358Abilify Maintena $357Cologuard Collection Kit $356Trintellix $355Creon $309Zavzpret $294Nexletol $285Veozah $279Austedo Xr $276Verquvo $273Jardiance $252Apretude $250Nexlizet $249Aristada $242Otezla $233Repatha $233Arexvy $204Paxlovid $196Rybelsus $195Mounjaro $178Gemtesa $171Fanapt $168Ohtuvayre $135Abilify Asimtufii $133Eliquis $129Ingrezza $125Opzelura $125Zoryve $121Dexcom G6 Transmitter $114Nuedexta $109Xarelto $108Xeomin $100Yupelri $98.34Symbravo $97.76Comirnaty $93.85Shingrix $84.63Azstarys $82.94Relistor $76.83Leqvio $72.00Freestyle Libre 2 $70.12Gralise $67.69Loreev Xr $67.69Prolate $62.96The Cologuard Plus Collection Kit $59.92Gvoke Hypopen $55.76Evenity $44.30Uzedy $43.77Emgality $42.09Eohilia $42.09Ibsrela $36.17Trudhesa $34.41Zepbound $34.02Auvelity $32.04Myrbetriq $31.55Tzield $31.27Zenpep $31.21Viberzi $30.80Quviviq $29.78Belsomra $27.09Toujeo $25.35Soliqua 100/33 $25.35Ragwitek $24.65Odactra $24.65Grastek $24.65Sertraline Hcl $23.34Jynarque $22.90Kisunla $22.47Entresto $21.69Senza $20.81Korlym $20.19Tlando $20.14Premarin $20.05Estring $20.05Sunosi $19.22Collagenase Santyl $18.58Myfembree $17.96Qsymia $17.53Trulance $16.64Nalocet $15.74Jatenzo $14.20
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Trejo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.